Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of drug targeting (Print)

• Publication date

  2017-01-25

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1080/1061186X.2017.1280809PMID 28122462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.

  2016cited by this paper
• Liposomes in topical ophthalmic drug delivery: an update

  2016cited by this paper
• Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice

  2016cited by this paper
• Incidence of myocardial infarction, stroke, and death in patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor therapy.

  2015cited by this paper
• A RANDOMIZED CONTROLLED TRIAL OF PANRETINAL PHOTOCOAGULATION WITH AND WITHOUT INTRAVITREAL RANIBIZUMAB IN TREATMENT-NAIVE EYES WITH NON–HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY

  2015cited by this paper
• Fenofibrate and diabetic retinopathy

  2015cited by this paper
• Re: Boyer et al.: Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema (Ophthalmology 2014;121:1904-14).

  2015influential reference
• Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration.

  2015cited by this paper
• Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina.

  2015cited by this paper
• In Vitro/In Vivo Evaluation of Dexamethasone--PAMAM Dendrimer Complexes for Retinal Drug Delivery.

  2015cited by this paper
• Subtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese population

  2014cited by this paper
• Derivation of Traceable and Transplantable Photoreceptors from Mouse Embryonic Stem Cells

  2014cited by this paper
• Scutellarin Inhibits High Glucose–induced and Hypoxia-mimetic Agent–induced Angiogenic Effects in Human Retinal Endothelial Cells Through Reactive Oxygen Species/Hypoxia-inducible Factor-1&agr;/Vascular Endothelial Growth Factor Pathway

  2014cited by this paper
• Epigalloccatechin-3-gallate Inhibits Ocular Neovascularization and Vascular Permeability in Human Retinal Pigment Epithelial and Human Retinal Microvascular Endothelial Cells via Suppression of MMP-9 and VEGF Activation

  2014cited by this paper
• Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

  2014cited by this paper
• Physicochemical characterization and toxicological evaluation of plant-based anionic polymers and their nanoparticulated system for ocular delivery

  2014cited by this paper
• A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation

  2014cited by this paper
• Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies

  2014cited by this paper
• Mesenchymal Stem Cells: New Players in Retinopathy Therapy

  2014cited by this paper
• Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.

  2014cited by this paper
• Therapeutic Potential of Topical Fenofibrate Eyedrops in Diabetic Retinopathy and AMD Rat Models

  2014cited by this paper
• Effect of Ranirestat, a New Aldose Reductase Inhibitor, on Diabetic Retinopathy in SDT Rats

  2014cited by this paper
• Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application

  2014cited by this paper
• Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.

  2014cited by this paper
• Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes

  2013cited by this paper
• Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina

  2013cited by this paper
• Engrafted Human Induced Pluripotent Stem Cell-Derived Anterior Specified Neural Progenitors Protect the Rat Crushed Optic Nerve

  2013cited by this paper
• Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

  2013cited by this paper
• WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors.

  2013cited by this paper
• Neural Stem Cells Derived by Small Molecules Preserve Vision.

  2013cited by this paper
• Human adipose‐derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation

  2013cited by this paper
• Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir

  2013cited by this paper
• A novel management of diabetes by means of strong antioxidants’ combination

  2013cited by this paper
• Retinal Pigmented Epithelial Cells Obtained from Human Induced Pluripotent Stem Cells Possess Functional Visual Cycle Enzymes in Vitro and in Vivo*

  2013cited by this paper
• Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer.

  2013cited by this paper
• Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema

  2013cited by this paper
• Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.

  2013cited by this paper
• RETINA REJUVENATION THERAPY FOR DIABETIC MACULAR EDEMA: A Pilot Study

  2013cited by this paper
• Nanoliposomal minocycline for ocular drug delivery.

  2013cited by this paper
• Fluocinolone Acetonide Intravitreal Implant (Iluvien®)

  2013cited by this paper
• Formulation and Evaluation of Betamethasone Sodium Phosphate Loaded Nanoparticles for Ophthalmic Delivery

  2013cited by this paper
• Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema.

  2013cited by this paper
• ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS

  2013cited by this paper
• Resveratrol blocks diabetes‐induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas

  2012cited by this paper
• Liposomes for intravitreal drug delivery: a state of the art.

  2012cited by this paper
• Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

  2012cited by this paper
• Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis

  2012cited by this paper
• Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.

  2012cited by this paper
• Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.

  2012cited by this paper
• Intravitreal Dexamethasone Implant in Patients with Persistent Diabetic Macular Edema

  2012influential reference
• Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process.

  2012cited by this paper
• Development of buccal tablets for curcumin using Anacardium occidentale gum

  2012cited by this paper
• Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review

  2012cited by this paper
• Regenerative Therapeutic Potential of Adipose Stromal Cells in Early Stage Diabetic Retinopathy

  2012cited by this paper
• Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts.

  2011cited by this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review

  2011cited by this paper
• Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.

  2011cited by this paper
• Fluocinolone acetonide implantable device for diabetic retinopathy.

  2011influential reference
• Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation.

  2011cited by this paper
• Role of adenosine in diabetic retinopathy

  2011cited by this paper
• Diabetic retinopathy (treatment).

  2011cited by this paper
• Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

  2011cited by this paper
• Drug delivery to the posterior segment of the eye.

  2011cited by this paper
• DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS

  2011influential reference
• Efficacy of Tetrandrine on Lowering Intraocular Pressure in Animal Model With Ocular Hypertension

  2011cited by this paper
• Polymeric vectors for ocular gene delivery.

  2011cited by this paper
• Sustained-release dexamethasone intravitreal implant for treatment of diabetic macular edema

  2011cited by this paper
• A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.

  2011cited by this paper
• Stem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases

  2011cited by this paper
• Recent Investigations of Plant Based Natural Gums, Mucilages and Resins in Novel Drug Delivery Systems

  2011cited by this paper
• Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

  2011cited by this paper
• Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.

  2011cited by this paper
• Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.

  2011cited by this paper
• Drug Delivery to the Posterior Segment of the Eye

  2011cited by this paper
• Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control

  2011cited by this paper
• Differentiation of Induced Pluripotent Stem Cells of Swine into Rod Photoreceptors and Their Integration into the Retina

  2011cited by this paper
• Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells.

  2010cited by this paper
• Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats

  2010cited by this paper
• New Developments in Corticosteroid Therapy for Uveitis

  2010cited by this paper
• Drug delivery to the posterior segment of the eye.

  2010cited by this paper
• Oxidative Damage and the Prevention of Age-Related Cataracts

  2010cited by this paper
• Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.

  2010cited by this paper
• Complications of intravitreal injections

  2010cited by this paper
• Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation

  2010cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2010cited by this paper
• Topical mecamylamine for diabetic macular edema.

  2010cited by this paper
• Surgical management of the late complications of proliferative diabetic retinopathy

  2010cited by this paper
• Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs

  2010cited by this paper
• Applications of nanoparticles in ophthalmology.

  2010cited by this paper
• Diabetic retinopathy

  2010cited by this paper
• COMPARISON OF CLINICAL OUTCOMES BETWEEN 23-GAUGE AND 20-GAUGE VITRECTOMY IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY

  2010cited by this paper
• Selective retina therapy (SRT) for clinically significant diabetic macular edema

  2010cited by this paper
• Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.

  2010cited by this paper
• Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration

  2009cited by this paper
• Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.

  2009cited by this paper
• Chitosan and its role in ocular therapeutics.

  2009cited by this paper
• Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.

  2009cited by this paper
• Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown*

  2009cited by this paper

• Recent Progress in Polymeric Micelle-Enabled Targeted Nanotherapeutics for Diabetic Retinopathy

  2024cites this paper
• TARGETING HIGH DOSE NIFEDIPINE-INDUCED HIPERTROPHY IN TISSUES WITH HYDROCORTISONE-LOADED NANOCARRIERS

  2024cites this paper
• Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review

  2024cites this paper
• Nanomaterials for diabetes: diagnosis, detection and delivery

  2024cites this paper
• Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy

  2024cites this paper
• Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations.

  2023cites this paper
• Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy

  2023cites this paper
• Recent Updates on Nanocarriers for Drug Delivery in Posterior Segment Diseases with Emphasis on Diabetic Retinopathy.

  2023cites this paper
• Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1/Parkin-Mediated Mitophagy in Diabetic Retinopathy

  2021cites this paper
• Nano Based Approach for the Treatment of Neglected Tropical Diseases

  2021cites this paper
• A review on albumin as a biomaterial for ocular drug delivery.

  2021cites this paper
• Identification of connexin43 in diabetic retinopathy and its downregulation by O-GlcNAcylation to inhibit the activation of glial cells.

  2021cites this paper
• Preparation of MED1(transcription mediator subunit) gene nanocarrier and its mechanism of action on liver cell regeneration in chronic acute liver failure

  2021cites this paper
• MiR-423-5p activated by E2F1 promotes neovascularization in diabetic retinopathy by targeting HIPK2

  2021cites this paper
• Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats

  2020cites this paper
• Preliminary research on the effects and mechanisms of umbilical cord‑derived mesenchymal stem cells in streptozotocin‑induced diabetic retinopathy.

  2020cites this paper
• Silencing cyclophilin A improves insulin secretion, reduces cell apoptosis, and alleviates inflammation as well as oxidant stress in high glucose-induced pancreatic β-cells via MAPK/NF-kb signaling pathway

  2020cites this paper
• Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy

  2020cites this paper
• Nanotechnology and Diabetes Management: Recent Advances and Future Perspectives

  2020cites this paper
• Investigation of glutamate receptors in human pancreatic β-cells and their role in insulin secretion

  2020cites this paper
• Role of Nanotechnology in Diabetic Management.

  2019cites this paper
• Nanoparticle Delivery Systems in the Treatment of Diabetes Complications

  2019cites this paper
• Schizandrin A Protects Human Retinal Pigment Epithelial Cell Line ARPE-19 against HG-Induced Cell Injury by Regulation of miR-145

  2019cites this paper
• Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells

  2018cites this paper
• Gac (Momordica cochinchinensis Spreng.) Fruit and its Potentiality and Superiority in -Health Benefits

  2018cites this paper
• : Pathogenesis, Clinical Features and the Role of Physical Activity in Prevention and Management

  year unknowncites this paper